CagriSema is filed for approval and represents Novo Nordisk's competitive response
For Wegovy, the FDA approves three maintenance options: 2.4 mg weekly the standard maintenance dose used in the STEP 1 and STEP 5 trials
4 Another trial enrolled adults with type 2 diabetes
The injectable pen comes in the same dose strengths available in the United States: 0.25 mg, 0.5 mg, 1 mg, and 2 mg
Focusing specifically on Mounjaro, a 2025 study in adults with type 1 diabetes and overweight or obesity found that after 21 months, participants experienced 23% weight loss, sustained improvements in glucose management, and significant improvements in blood pressure, cholesterol, triglycerides , and eGFR (a marker of kidney function)
A consult makes it possible to build a plan instead of guessing